MedPath

上海丽珠制药有限公司

Ownership
-
Established
1995-04-11
Employees
-
Market Cap
-
Website
http://www.shlivzon.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

44

NMPA:44

Drug Approvals

醋酸奥曲肽

Approval Number
国药准字H20090274
Approval Date
May 11, 2024
NMPA

醋酸亮丙瑞林

Approval Number
国药准字H20090299
Approval Date
Apr 28, 2024
NMPA

注射用醋酸亮丙瑞林微球

Approval Number
国药准字H20093852
Approval Date
Apr 28, 2024
NMPA

注射用绒促性素

Approval Number
国药准字H20033377
Approval Date
Jun 11, 2020
NMPA

注射用绒促性素

Approval Number
国药准字H20033378
Approval Date
Jun 11, 2020
NMPA

注射用尿促性素

Approval Number
国药准字H20023864
Approval Date
Jun 11, 2020
NMPA

注射用绒促性素

Approval Number
国药准字H20033379
Approval Date
Jun 11, 2020
NMPA

注射用尿促性素

Approval Number
国药准字H20023863
Approval Date
Jun 11, 2020
NMPA

Thymopolypeptides Injection

Product Name
胸腺肽注射液
Approval Number
国药准字H20003884
Approval Date
May 12, 2020
NMPA

Deproteinized Calf blood Extractives Injection

Product Name
小牛血去蛋白提取物注射液
Approval Number
国药准字H20003603
Approval Date
May 12, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.